Cited by 3,559Angiogenesis and VEGF in CancerCancer Cells and MetastasisMathematical Biology Tumor Growth

The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.

Tumorigenesis and the angiogenic switch

Bergers, Gabriele, Benjamin, Laura E.·2003·Nature reviews. Cancer

Open this paper in CoChat — free account

Abstract

It has become evident that we cannot understand tumour growth without considering components of the stromal microenvironment, such as the vasculature. At the same time, the tumour phenotype determines the nature of the tumour vasculature. Much research is now devoted to determining the impact of angiogenesis on tumour development and progression, and the reciprocal influences of tumour products on the microvasculature. A more detailed understanding of the complex parameters that govern the interactions between the tumour and vascular compartments will help to improve anti-angiogenic strategies-- not only for cancer treatment, but also for preventing recurrence.

Integrity signals

Registry

Crossref · 10.1038/nrc1093

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis
Watnick, R. S., Cheng, Y.-N., Rangarajan, A., Ince, T. A., & Weinberg, R. A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00030-8 · Cited by 318
Retracted
The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., de Vries-Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,704
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Mechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,235
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699

Flagged first, then by citations

Show all 110 references

Research works printed but not linked: 2

Folkman, J. in Cancer Medicine (Holland, M.D. et al.) 2546 (BC Decker, Hamilton, Ontario, 2000).
Sternlicht, M. D. et al. Matrix proteinases as emerging targets in anticancer therapy: status and prospects. ETT 4, 609–633 (2000).

Sorted by citations

Items 501–600 of 1,010

Hwanggeumchal sorghum Induces Cell Cycle Arrest, and Suppresses Tumor Growth and Metastasis through Jak2/STAT Pathways in Breast Cancer Xenografts
Park, J., Darvin, P., Lim, E. J., Joung, Y. H., Hong, D. Y., Park, E. U., Park, S. H., Choi, S.-K., Moon, E.-S., Cho, B. W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040531 · Cited by 100
Macrophages and Fibroblasts, Key Players in Cancer Chemoresistance
Ireland, L., & Mielgo, A. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00131 · Cited by 106
“The activation of the angiogenic switch in tumors triggers dysregulated angiogenesis resulting in leaky vasculature with abnormal branching and enlarged diameter (Bergers and Benjamin, 2003).”
Background
Tumor-associated macrophages: a short compendium
Prenen, H., & Mazzone, M. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2997-3 · Cited by 103
Deep-tissue optical imaging of near cellular-sized features
Dang, X., Bardhan, N. M., Qi, J., Gu, L., Eze, N. A., Lin, C., Kataria, S., Hammond, P. T., & Belcher, A. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-39502-w · Cited by 106
Coexpression of Angiogenic Factors in Brain Arteriovenous Malformations
Hashimoto, T. N., Wu, Y., Lawton, M. T., Yang, G., Barbaro, N. M., & Young, W. L. (2005) · Neurosurgery · doi:10.1227/01.neu.0000157925.19676.c3 · Cited by 102
Mechanisms of resistance to vascular endothelial growth factor blockade
Abdullah, S. E., & Perez-Soler, R. (2011) · Cancer · doi:10.1002/cncr.26540 · Cited by 104
T Cells Bearing a Chimeric Antigen Receptor against Prostate-Specific Membrane Antigen Mediate Vascular Disruption and Result in Tumor Regression
Santoro, S. P., Kim, S., Motz, G. T., Alatzoglou, D., Li, C., Irving, M. B., Powell, D. J., & Coukos, G. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0192 · Cited by 102
Toward Brain Tumor Gene Therapy Using Multipotent Mesenchymal Stromal Cell Vectors
Bexell, D., Scheding, S., & Bengzon, J. (2010) · Molecular Therapy · doi:10.1038/mt.2010.58 · Cited by 101
VEGF Trap induces antiglioma effect at different stages of disease
Gomez‐Manzano, C., Holash, J. A., Fueyo-Margareto, J., Xu, J., Conrad, C. A., Aldape, K., de Groot, J. F., Bekele, B. N., & Yung, W. K. A. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-061 · Cited by 101
Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer
Mukherjee, A., Madamsetty, V. S., Paul, M. K., & Mukherjee, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020455 · Cited by 101
Precancerous Stem Cells Can Serve As Tumor Vasculogenic Progenitors
Shen, R. Z., Ye, Y., Chen, L., Yan, Q., Barsky, S. H., & Gao, J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001652 · Cited by 102
Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesis
Zhang, K., Hu, S., Wu, J., Chen, L., Lu, J., Wang, X., Liu, X., Zhou, B., & Yen, Y. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-11 · Cited by 101
Inhibition of Xenografted Human Melanoma Growth and Prevention of Metastasis Development by Dual Antiangiogenic/Antitumor Activities of Pigment Epithelium-Derived Factor
García, M., Fernandez-Garcia, N. I., Rivas, V., Carretero, M., Escamez, M. J., González-Martín, A., Medrano, E. E., Volpert, O. V., Jorcano, J. L., Jiménez, B., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0230 · Cited by 101
Molecular imaging with SPECT as a tool for drug development
Gomes, C. M., Abrunhosa, A. J., Ramos, P., & Pauwels, E. K. J. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.09.015 · Cited by 100
Harnessing Protease Activity to Improve Cancer Care
Dudani, J. S., Warren, A., & Bhatia, S. N. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050549 · Cited by 103
KIF4A facilitates cell proliferation via induction of p21-mediated cell cycle progression and promotes metastasis in colorectal cancer
Hou, P., Jiang, T., Chen, F., Shi, P.-C., Li, H., Bai, J., & Song, J. H. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0550-9 · Cited by 100
Antiangiogenic and antitumoral properties of a polysaccharide isolated from the seaweed Sargassum stenophyllum
Dias, P. F., Siqueira, J. M., Vendruscolo, L. F., Neiva, T. D. J. C., Gagliardi, A. R. D. T., Maraschin, M., & Ribeiro‐do‐Valle, R. M. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0995-7 · Cited by 99
z-Guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, inhibits angiogenesis in vitro and in vivo
Xiao, D., & Singh, S. V. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0491 · Cited by 100
SKLB1002, a Novel Potent Inhibitor of VEGF Receptor 2 Signaling, Inhibits Angiogenesis and Tumor Growth In Vivo
Zhang, S., Cao, Z., Tian, H., Shen, G., Ma, Y., Xie, H., Liu, Y., Zhao, C., Deng, S., Yang, Y., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3109 · Cited by 101
Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer
Loizzi, V., Vecchio, V. D., Gargano, G., Liso, M. D., Kardashi, A., Naglieri, E., Resta, L., Cicinelli, E., & Cormio, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091967 · Cited by 99
The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment
Reynders, N., Abboud, D., Baragli, A., Noman, M. Z., Rogister, B., Niclou, S. P., Heveker, N., Janji, B., Hanson, J., Szpakowska, M., et al. (2019) · Cells · doi:10.3390/cells8060613 · Cited by 99
Microfluidics for detection of exosomes and microRNAs in cancer: State of the art
Mousavi, S. M., Mahdian, S. M. A., Ebrahimi, M. S., Taghizadieh, M., Vosough, M., Nahand, J. S., Hosseindoost, S., Vousooghi, N., Javar, H. A., Larijani, B. A., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.04.011 · Cited by 100
Hypoxic Regulation of Vascular Endothelial Growth Factor through the Induction of Phosphatidylinositol 3-Kinase/Rho/ROCK and c-Myc
Mizukami, Y., Fujiki, K., Duerr, E., Gala, M. K., Jo, W., Zhang, X., & Chung, D. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511763200 · Cited by 99
Nitric oxide delivery to cancer: Why and how?
Sonveaux, P., Jordan, B. F., Gallez, B., & Féron, O. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.12.018 · Cited by 103
Role of the hypoxic bone marrow microenvironment in 5T2MM murine myeloma tumor progression.
Asosingh, K., Raeve, H. D., Ridder, M. D., Storme, G. A., Willems, A., Riet, I. V., Camp, B. V., & Vanderkerken, K. (2005) · PubMed · Cited by 97
Cellular Constituents of the Prostate Stroma: Key Contributors to Prostate Cancer Progression and Therapy ResistancePreprint
Levesque, C., & Nelson, P. S. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030510 · Cited by 101
VEGF in Tumor Progression and Targeted Therapy
Chekhonin, V. P., Shein, S. A., Korchagina, A. A., & Gurina, O. I. (2013) · Current Cancer Drug Targets · doi:10.2174/15680096113139990074 · Cited by 99
MicroRNA ‐542‐3p inhibits tumour angiogenesis by targeting Angiopoietin‐2
He, T., Qi, F., Jia, L., Wang, S., Song, N., Guo, L., Fu, Y., & Luo, Y. (2014) · The Journal of Pathology · doi:10.1002/path.4324 · Cited by 97
Central role of lactate and proton in cancer cell resistance to glucose deprivation and its clinical translation
Hu, X., Chao, M., & Wu, H. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2016.47 · Cited by 102
Dysregulation of protein synthesis and disease
Quesne, J. P. C. L., Spriggs, K. A., Bushell, M., & Willis, A. E. (2009) · The Journal of Pathology · doi:10.1002/path.2627 · Cited by 102
Assessing responses to cancer therapy using molecular imaging
Neves, A., & Brindle, K. M. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.10.002 · Cited by 98
Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease
Bluff, J. E., Menakuru, S. R., Cross, S. S., Higham, S. E., Balasubramanian, S. P., Brown, N. J., Reed, M., & Staton, C. A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605196 · Cited by 98
Overexpression of Platelet-Derived Growth Factor Receptor α in Endothelial Cells of Hepatocellular Carcinoma Associated with High Metastatic Potential
Zhang, T., Sun, H., Xu, Y. Y., Zhang, K., Wang, L., Qin, L., Wu, W., Liu, Y., Ye, S., & Tang, Z. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0944 · Cited by 97
Oxygen-Controlled Three-Dimensional Cultures to Analyze Tumor Angiogenesis
Verbridge, S. S., Choi, N., Zheng, Y. Y., Brooks, D. J., Stroock, A. D., & Fischbach, C. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0670 · Cited by 99
Natural products against cancer angiogenesis
Bairi, K. E., El-Kenawy, A. E.-M., Rahman, H. S., Guaâdaoui, A., & Najda, A. (2016) · Tumor Biology · doi:10.1007/s13277-016-5364-8 · Cited by 99
Tumor Immune Microenvironment and Immunotherapy in Non-Small Cell Lung Cancer: Update and New Challenges
Xing, S., Hu, K., & Wang, Y. (2022) · Aging and Disease · doi:10.14336/ad.2022.0407 · Cited by 98
“Moreover, tumor cells promote angiogenesis [10], epithelial-mesenchymal transition [11], and extracellular matrix remodeling [12] by changing the local metabolic environment and/or releasing extracellular signals to facilitate their survival and development in the body.”
Background
Peptide‐based Molecules in Angiogenesis
D’Andrea, L. D., Gatto, A. D., Pedone, C., & Benedetti, E. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2006.00356.x · Cited by 96
Increased Survivin Expression Confers Chemoresistance to Tumor-Associated Endothelial Cells
Virrey, J. J., Guan, S., Li, W., Schönthal, A. H., Chen, T. C., & Hofman, F. M. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.071079 · Cited by 96
Bevacizumab Suppression of Establishment of Micrometastases in Experimental Ocular Melanoma
Yang, H., Jager, M. J., & Grossniklaus, H. E. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4755 · Cited by 96
Molecular mechanism inhibiting human hepatocarcinoma cell invasion by 6‐shogaol and 6‐gingerol
Weng, C., Chou, C., Ho, C., & Yen, G. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200173 · Cited by 96
Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments
Cardoso, A. C. F., Andrade, L. N. D. S., Bustos, S. O., & Chammas, R. J. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00127 · Cited by 101
New concepts and best practices for management of pre- and post-transplantation cancer
Campistol, J. M., Cuervas‐Mons, V., Manito, N., Almenar, L., Arias, M., Casafont, F., del Castillo, D., Crespo-Leiro, M. G., Delgado, J. F., Herrero, J. I., et al. (2012) · Transplantation Reviews · doi:10.1016/j.trre.2012.07.001 · Cited by 96
Imaging of Tumor Angiogenesis: Functional or Targeted?
Türkbey, B., Kobayashi, H., Ogawa, M., Bernardo, M., & Choyke, P. L. (2009) · American Journal of Roentgenology · doi:10.2214/ajr.09.2869 · Cited by 95
Expression of activated platelet‐derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential
Kitadai, Y., Sasaki, T., Kuwai, T., Nakamura, T., Bucana, C. D., Hamilton, S. R., & Fidler, I. J. (2006) · International Journal of Cancer · doi:10.1002/ijc.22229 · Cited by 95
The "Two-Faced" Effects of Reactive Oxygen Species and the Lipid Peroxidation Product 4-Hydroxynonenal in the Hallmarks of Cancer
Pizzimenti, S., Toaldo, C., Pettazzoni, P., Dianzani, M. U., & Barrera, G. (2010) · Cancers · doi:10.3390/cancers2020338 · Cited by 98
The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer
Missiaen, R., Mazzone, M., & Bergers, G. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.06.002 · Cited by 96
“Thus, under physiological conditions angiogenesis is tightly regulated by a homeostatic balance of a wealth of proangiogenic and inhibitory factors of which members of the vascular endothelial growth factor (VEGF), and angiopoietin tyrosine kinase receptor families as well as various members of the CXC and CC chemokin…”
Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes
Ruan, J., Luo, M., Wang, C., Fan, L., Yang, S. N., Cárdenas, M., Geng, H., Leonard, J. P., Melnick, A. M., Cerchietti, L. C. A., et al. (2013) · Blood · doi:10.1182/blood-2013-03-490763 · Cited by 94
Celecoxib analogs that lack COX-2 inhibitory function: preclinical development of novel anticancer drugs
Schönthal, A. H., Chen, T. C., Hofman, F. M., Louie, S. G., & Petasis, N. A. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.2.197 · Cited by 95
Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors
OLSSON, A. G., Björk, A., Vallon‐Christersson, J., Isaacs, J. T., & Leanderson, T. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-107 · Cited by 94
SCFβ-TRCP suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2
Shaik, S., Nucera, C., Inuzuka, H., Gao, D., Garnaas, M., Frechette, G. M., Harris, L. N., Wan, L., Fukushima, H., Husain, A., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20112446 · Cited by 93
Hedgehog pathway and GLI1 isoforms in human cancer.
Carpenter, R. L., & Lo, H. (2012) · PubMed · Cited by 93
The Yin and Yang of bone morphogenetic proteins in cancer
Singh, A. K., & Morris, R. J. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.06.003 · Cited by 93
Breast cancer cells secreted platelet‐derived growth factor‐induced motility of vascular smooth muscle cells is mediated through neuropilin‐1
Banerjee, S., Sengupta, K., Dhar, K., Mehta, S., D'Amore, P. A., Dhar, G., & Banerjee, S. K. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20248 · Cited by 93
Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1α activity and vascular endothelial growth factor expression in small cell lung cancer cells
Litz, J., & Krystal, G. W. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0503 · Cited by 93
BMPs and their clinical potentials
Kim, M.-J., & Choe, S. (2011) · BMB Reports · doi:10.5483/bmbrep.2011.44.10.619 · Cited by 97
Multitarget drugs: the present and the future of cancer therapy
Petrelli, A., & Valabrega, G. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902781907 · Cited by 93
Oncogenic Ras-Induced Expression of Cytokines: A New Target of Anti-Cancer Therapeutics
Ancrile, B. B., O’Hayer, K., & Counter, C. M. (2008) · Molecular Interventions · doi:10.1124/mi.8.1.6 · Cited by 91
Effects of angiogenic factors and 3D-microenvironments on vascularization within sandwich cultures
Nishiguchi, A., Matsusaki, M., Asano, Y., Shimoda, H., & Akashi, M. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.079 · Cited by 93
Apoptosis initiation and angiogenesis inhibition: melanoma targets for nanosecond pulsed electric fields
Chen, X., Kolb, J. F., Swanson, R. J., Schoenbach, K. H., & Beebe, S. J. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00704.x · Cited by 92
Molecular Imaging Applications in Nanomedicine
Li, K. C., Pandit, S. D., Guccione, S., & Bednarski, M. D. (2004) · Biomedical Microdevices · doi:10.1023/b:bmmd.0000031747.05317.81 · Cited by 90
Angiogenic activity of nicotinic acetylcholine receptors: Implications in tobacco-related vascular diseases
Egleton, R. D., Brown, K. C., & Dasgupta, P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.10.007 · Cited by 91
Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE-cadherin/EphA2/MMP9/MMP2 expression
Guo, J.-Q., Zheng, Q., Chen, H., Chen, L., Xu, J., Chen, M., Lu, D., Wang, Z., Tong, H., & Lin, S. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2500 · Cited by 91
Potent inhibition of Lewis lung cancer growth by heyneanol A from the roots of Vitis amurensis through apoptotic and anti-angiogenic activities
Lee, E. O. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl055 · Cited by 91
Evaluation of Tumor Microenvironment in an Animal Model using a Nanoparticle Contrast Agent in Computed Tomography Imaging
Ghaghada, K. B., Badea, C. T., Karumbaiah, L., Fettig, N. M., Bellamkonda, R. V., Johnson, G. A., & Annapragada, A. (2010) · Academic Radiology · doi:10.1016/j.acra.2010.09.003 · Cited by 91
Inflamed tumor-associated adipose tissue is a depot for macrophages that stimulate tumor growth and angiogenesis
Wagner, M., Bjerkvig, R., Wiig, H., Melero-Martin, J. M., Lin, R.-Z., Klagsbrun, M., & Dudley, A. C. (2012) · Angiogenesis · doi:10.1007/s10456-012-9276-y · Cited by 91
Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities
Eapen, M. S., Hansbro, P. M., Larsson‐Callerfelt, A., Jolly, M. K., Myers, S., Sharma, P. K., Jones, B., Rahman, M. A., Markos, J., Chia, C., et al. (2018) · Drugs · doi:10.1007/s40265-018-1001-8 · Cited by 93
Gold Nanoparticles Induce Tumor Vessel Normalization and Impair Metastasis by Inhibiting Endothelial Smad2/3 Signaling
Huang, N., Liu, Y., Fang, Y. V., Zheng, S., Wu, J., Wang, M., Zhong, W., Shi, M., Xing, M. M. Q., & Liao, W. (2020) · ACS Nano · doi:10.1021/acsnano.9b08460 · Cited by 90
Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments
Alghamri, M. S., McClellan, B. L., Hartlage, C. S., Haase, S., Faisal, S. M., Thalla, R., Dabaja, A. A., Banerjee, K., Carney, S. V., Mujeeb, A., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.680021 · Cited by 94
“These include but are not limited to activation of hypoxia, abnormal angiogenesis, and tissue remodeling which disrupt the BBB and trigger an inflammatory response in the brain microenvironment (Bergers and Benjamin, 2003; Allavena et al., 2008; Ros et al., 2018).”
Background
Hypoxia-dependent drivers of melanoma progression
D’Aguanno, S., Mallone, F., Marenco, M., Bufalo, D. D., & Moramarco, A. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01926-6 · Cited by 96
Perillyl Alcohol Is an Angiogenesis Inhibitor
Loutrari, H. V., Hatziapostolou, M., Skouridou, V., Papadimitriou, Ε., Roussos, C., Kolisis, F. N., & Papapetropoulos, A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.070516 · Cited by 90
Reduced pathological angiogenesis and tumor growth in mice lacking GPR4, a proton sensing receptor
Wyder, L., Suply, T., Ricoux, B., Billy, É., Schnell, C., Baumgarten, B. U., Maira, S.-M., Koelbing, C., Ferretti, M., Kinzel, B., et al. (2011) · Angiogenesis · doi:10.1007/s10456-011-9238-9 · Cited by 91
Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition
Yoo, J. Y., Kim, J.-H., Kim, J., Huang, J.-H., Zhang, S.-N., Kang, Y.-A., Kim, H., & Yun, C.-O. (2008) · Gene Therapy · doi:10.1038/gt.2008.3 · Cited by 90
In vivo Imaging of the Systemic Recruitment of Fibroblasts to the Angiogenic Rim of Ovarian Carcinoma Tumors
Granot, D., Addadi, Y., Kalchenko, V., Harmelin, A., Kunz‐Schughart, L. A., & Neeman, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0684 · Cited by 90
Adjuvant Vascular Endothelial Growth Factor–targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis
Sun, M., Marconi, L. S., Eisen, T. G., Escudier, B. J., Giles, R. H., Haas, N. B., Harshman, L. C., Quinn, D. I., Larkin, J., Pal, S. K., et al. (2018) · European Urology · doi:10.1016/j.eururo.2018.05.002 · Cited by 89
Proteolytically Processed Soluble Tumor Endothelial Marker (TEM) 5 Mediates Endothelial Cell Survival during Angiogenesis by Linking Integrin αvβ3 to Glycosaminoglycans
Vallon, M., & Essler, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605291200 · Cited by 89
Targeting Anticancer Drugs to Tumor Vasculature Using Cationic Liposomes
Lila, A. S. A., Ishida, T., & Kiwada, H. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0110-1 · Cited by 89
Use of Nanotechnology to Develop Multi-Drug Inhibitors for Cancer Therapy
Gowda, R. (2013) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000184 · Cited by 92
Microtubule-targeting agents in angiogenesis: Where do we stand?
Pasquier, E., Honoré, S., & Braguer, D. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.04.003 · Cited by 89
Intravoxel incoherent motion MRI for predicting early response to induction chemotherapy and chemoradiotherapy in patients with nasopharyngeal carcinoma
Yu, X., Hou, J., Li, F., Hu, Y., Lu, Q., Wang, L., & Wei, W. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25075 · Cited by 89
TGF-Beta Suppresses VEGFA-Mediated Angiogenesis in Colon Cancer Metastasis
Geng, L., Chaudhuri, A., Talmon, G. A., Wisecarver, J. L., & Wang, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059918 · Cited by 88
Plasticity beyond Cancer Cells and the “Immunosuppressive Switch”
Granot, Z., & Fridlender, Z. G. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1502 · Cited by 93
Silencing PFKP inhibits starvation-induced autophagy, glycolysis, and epithelial mesenchymal transition in oral squamous cell carcinoma
Chen, G., Liu, H., Zhang, Y., Liang, J., Zhu, Y., Zhang, M., Yu, D., Wang, C., & Hou, J. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.06.007 · Cited by 88
Novel 2-indolinone thiazole hybrids as sunitinib analogues: Design, synthesis, and potent VEGFR-2 inhibition with potential anti-renal cancer activity
Mahmoud, H. K., Farghaly, T. A., Abdulwahab, H. G., Al‐Qurashi, N. T., & Shaaban, M. R. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112752 · Cited by 88
Gene co-expression in the interactome: moving from correlation toward causation via an integrated approach to disease module discovery
Paci, P., Fiscon, G., Conte, F., Wang, R., Farina, L., & Loscalzo, J. (2021) · npj Systems Biology and Applications · doi:10.1038/s41540-020-00168-0 · Cited by 87
An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress
Mehrzadi, S., Pourhanifeh, M. H., Mirzaei, A., Moradian, F., & Hosseinzadeh, A. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01892-1 · Cited by 96
The Good, the Bad, and the Ugly: Neutrophils, Angiogenesis, and Cancer
Ozel, I., Duerig, I., Domnich, M., Lang, S., Pylaeva, E., & Jabłońska, J. (2022) · Cancers · doi:10.3390/cancers14030536 · Cited by 94
VEGF gene alternative splicing: pro- and anti-angiogenic isoforms in cancer
Biselli-Chicote, P. M., Oliveira, A. R. C. P., Pavarino, É. C., & Goloni‐Bertollo, E. M. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1073-2 · Cited by 93
Molecular ultrasound assessment of tumor angiogenesis
Deshpande, N., Pysz, M. A., & Willmann, J. K. (2010) · Angiogenesis · doi:10.1007/s10456-010-9175-z · Cited by 90
Progestin-Dependent Progression of Human Breast Tumor Xenografts: A Novel Model for Evaluating Antitumor Therapeutics
Liang, Y., Besch-Williford, C. L., Brekken, R. A., & Hyder, S. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1103 · Cited by 88
The angiogenic process as a therapeutic target in cancer
Bridges, E., & Harris, A. L. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.02.016 · Cited by 87
Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer
Romain, B., Hachet‐Haas, M., Rohr, S., Brigand, C., Galzi, J., Gaub, M., Pencreach, E., & Guénot, D. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-58 · Cited by 94
Vasculogenic Mimicry in Breast Cancer: Clinical Relevance and Drivers
Morales-Guadarrama, G., Garcı́a-Becerra, R., Méndez-Pérez, E. A., García‐Quiroz, J., Avila, E., & Dı́az, L. (2021) · Cells · doi:10.3390/cells10071758 · Cited by 86
Challenges towards Targeted Drug Delivery in Cancer Nanomedicines
Hafeez, M. N., Celia, C., & Petrikaitė, V. (2021) · Processes · doi:10.3390/pr9091527 · Cited by 91
“Newly formed vessels are structurally and anatomically abnormal, having saccular endothelium with large fenestrations [28,29].”
Background
Novel Drugs with High Efficacy against Tumor Angiogenesis
Qi, S., Deng, S., Lian, Z., & Yu, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136934 · Cited by 88
Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases
Nijsten, T. E. C., Colpaert, C., Vermeulen, P., Harris, A. L., Marck, E. V., & Lambert, J. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06214.x · Cited by 87
High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT–PCR mRNA expression profile
Baldewijns, M. M. L. L., Thijssen, V. L., den Eynden, G. G. V., Laere, S. V., Bluekens, A. M. J., Roskams, T., Poppel, H. V., A, A. P. D. B., Griffioen, A. W., & Vermeulen, P. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603796 · Cited by 87
Novel endothelial cell markers in hepatocellular carcinoma
Chen, X., Higgins, J., Cheung, S., Li, R., Mason, V., Montgomery, K. D., Fan, S.-T., van de Rijn, M., & So, S. K. (2004) · Modern Pathology · doi:10.1038/modpathol.3800167 · Cited by 87
Nuclear factor 90 promotes angiogenesis by regulating HIF-1α/VEGF-A expression through the PI3K/Akt signaling pathway in human cervical cancer
Zhang, W., Xiong, Z., Wei, T., Li, Q., Tan, Y. C., Li, L., & Feng, X. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0334-2 · Cited by 86
CXCL17 Expression by Tumor Cells Recruits CD11b+Gr1highF4/80− Cells and Promotes Tumor Progression
Matsui, A., Yokoo, H., Negishi, Y., Endo‐Takahashi, Y., Chun, N. A. L., Kadouchi, I., Suzuki, R., Maruyama, K., Aramaki, Y., Semba, K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044080 · Cited by 86
VEGF profiling and angiogenesis in human microtissues
Kelm, J. M., Sánchez-Bustamante, C. D., Ehler, E., Hoerstrup, S. P., Djonov, V., Ittner, L. M., & Fussenegger, M. (2005) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2005.03.016 · Cited by 86

Authors: Bergers, G., & Benjamin, L. E.
Affiliations: University of California, San Francisco (US)
Beth Israel Deaconess Medical Center (US)
Corresponding author: Bergers, Gabriele
ORCID: Bergers, Gabriele
Venue: Nature reviews. Cancer
Publisher: Springer Science and Business Media LLC
Published: 2003-06
Volume: 3
Issue: 6
Pages: 401-410
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc1093
OpenAlex: W2804842145
Cited by: 3,559
References: 110
Citations by year: 2026: 53 · 2025: 79 · 2024: 123 · 2023: 122 · 2022: 142 · 2021: 160 · 2020: 149 · 2019: 159 · 2018: 162 · 2017: 176 · 2016: 148 · 2015: 176 · 2014: 232 · 2013: 223 · 2012: 198
FWCI: 9.49
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
Keywords: carcinogenesis, angiogenic switch, tumor angiogenesis, tumor vasculature, tumor microenvironment, tumor-stroma interactions, tumor progression, anti-angiogenic therapy, tumor recurrence
MeSH terms: Animals, Humans, Neoplasms, Neovascularization, Pathologic, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tumorigenesis and the angiogenic switch

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks